Aurologistics Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Aurologistics Llc Pharmaceutical Import Records from India — 22 Products, $32.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aurologistics Llc — Pharmaceutical Importer Profile (2026) | 22 Products, $32.8M Trade | TransData Nexus

Aurologistics Llc

Pharmaceutical Importer · United States · Cardiovascular Focus · $32.8M Total Trade · DGFT Verified

Aurologistics Llc is a pharmaceutical importer based in United States with a total trade value of $32.8M across 22 products in 12 therapeutic categories. Based on 715 verified import shipments from Indian Customs (DGFT) records, Aurologistics Llc is the #1 buyer in 1 product including Ribavirin. Aurologistics Llc sources from 2 verified Indian suppliers, with Aurobindo Pharma Limited accounting for 89.7% of imports.

Aurologistics Llc — Import Portfolio & Supplier Network

Aurologistics Llc import network — 22 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Aurologistics Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$268.0M	7,967	89.7%
Eugia Pharma Specialities Limited	$30.7M	732	10.3%

Aurologistics Llc sources from 2 verified Indian suppliers across 4,228 distinct formulations.

What Formulations Does Aurologistics Llc Import?

Formulation	Value	Ships
Venlafaxine hydrochloride extended	$4.3M	113
Amoxicillin & clavulanate potassium	$3.5M	69
Amoxicillin & clavulanate potassium	$2.8M	78
Venlafaxine hydrochloride	$2.7M	60
Ondansetron orally disintegrating	$2.7M	70
Amoxicillin for oral suspension	$2.3M	66
Levetiracetam oral solution 100MG/ML	$2.0M	43
Dorzolamide hydrochloride/timolol	$2.0M	44
Losartan potassium and	$1.7M	37
Pantoprazole sodium for injection 40 MG	$1.7M	34
Metoprolol tartrate tablets 50MG	$1.4M	33
Finasteride tablets 5MG (finasteride TAB	$1.3M	35
Clopidogrel tablets 75MG (clopidogrel	$1.2M	25
Losartan potassium and	$1.1M	24
Sumatriptan succinate tablets 100MG	$1.1M	26

Aurologistics Llc imports 4,228 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 22 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rosuvastatin	Cardiovascular	$4.5M	90	1.0%	11
2	Metoprolol	Cardiovascular	$3.3M	67	0.4%	17
3	Citalopram	CNS & Psychiatric	$3.0M	60	1.2%	10
4	Losartan	Cardiovascular	$3.0M	60	1.0%	9
5	Clopidogrel	Cardiovascular	$3.0M	59	1.2%	6
6	Ondansetron	Gastrointestinal	$2.4M	47	1.9%	9
7	Escitalopram	CNS & Psychiatric	$1.7M	34	0.9%	6
8	Carvedilol	Cardiovascular	$1.6M	32	1.6%	10
9	Ciprofloxacin	Antibiotics	$1.5M	30	0.5%	17
10	Terbinafine	Antifungals	$1.4M	32	2.4%	4
11	Pioglitazone	Diabetes & Endocrine	$1.3M	43	3.4%	7
12	Spironolactone	Diuretics	$950.0K	19	0.5%	12
13	Clindamycin	Antibiotics	$800.0K	16	0.9%	11
14	Torsemide	Diuretics	$722.0K	27	4.0%	3
15	Atenolol	Cardiovascular	$643.1K	25	1.6%	16
16	Niacin	Lipid & Metabolism	$588.1K	20	14.5%	2
17	Minocycline	Advanced Antibiotics	$550.0K	11	2.4%	6
18	Emtricitabine	Antiviral & HIV Medications	$500.0K	10	0.4%	16
19	Cefpodoxime	Advanced Antibiotics	$400.0K	8	0.3%	10
20	Cephalexin	Antibiotics	$400.0K	8	0.1%	14
21	Repaglinide	Advanced Diabetes Medications	$400.0K	8	4.3%	7
22	Ribavirin	Antivirals	$279.1K	9	43.2%	1

Aurologistics Llc imports 22 pharmaceutical products across 12 categories into United States totaling $32.8M. The company is the #1 buyer for 1 product: Ribavirin.

Aurologistics Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Aurologistics LLC is a prominent pharmaceutical importer and distributor based in East Windsor, New Jersey, United States. Established in 2015, the company specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Operating as a subsidiary of Aurobindo Pharma USA Inc., Aurologistics LLC plays a pivotal role in delivering a diverse range of pharmaceutical products to the U.S. market. The company's strategic focus on sourcing high-quality generics and specialty pharmaceuticals aligns with the growing demand for cost-effective healthcare solutions in the United States.

With a robust annual revenue of approximately $120 million, Aurologistics LLC has solidified its position as a key player in the pharmaceutical distribution sector. The company's extensive import activities underscore its commitment to ensuring a steady supply of essential medications to meet the needs of healthcare providers and patients nationwide. By leveraging its strong industry partnerships and global sourcing capabilities, Aurologistics LLC continues to enhance its service delivery and contribute to the efficiency of the U.S. pharmaceutical supply chain.

2Distribution Network

Aurologistics LLC operates a vertically integrated supply chain, facilitating the efficient movement of pharmaceutical products from international suppliers to U.S. markets. The company manages two distribution centers strategically located to optimize logistics and ensure timely delivery across the United States. These facilities are equipped with advanced technologies to support inventory management, order fulfillment, and compliance with regulatory standards. The distribution network is designed to handle a high volume of shipments, reflecting the company's capacity to meet the diverse needs of its clientele.

The logistics capabilities of Aurologistics LLC are further enhanced by its partnerships with major international suppliers, including Aurobindo Pharma Limited and Eugia Pharma Specialities Limited. These collaborations enable the company to source a wide array of pharmaceutical products, ensuring a comprehensive portfolio that caters to various therapeutic areas. The geographic coverage of Aurologistics LLC extends beyond the United States, with import activities involving ports in India, Oman, Sri Lanka, Spain, and other regions. This global sourcing strategy underscores the company's commitment to maintaining a resilient and responsive supply chain.

3Industry Role

In the United States pharmaceutical supply chain, Aurologistics LLC functions primarily as a pharmaceutical importer and distributor. The company is not a wholesaler, parallel importer, hospital supplier, or logistics intermediary; instead, it focuses on the importation and distribution of finished pharmaceutical formulations sourced from international suppliers. By managing the import process, including compliance with U.S. Food and Drug Administration (FDA) regulations, Aurologistics LLC ensures that imported drugs meet the necessary standards for quality, safety, and effectiveness. This role is crucial in maintaining the integrity of the U.S. pharmaceutical market and ensuring that healthcare providers have access to a reliable supply of medications.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Aurologistics Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Aurologistics LLC demonstrates a high degree of supplier concentration, with its primary sourcing activities focused on two Indian pharmaceutical manufacturers: Aurobindo Pharma Limited and Eugia Pharma Specialities Limited. Aurobindo Pharma Limited accounts for approximately 89.7% of the company's total import value, while Eugia Pharma Specialities Limited contributes about 10.3%. This sourcing strategy indicates a strategic choice to establish strong partnerships with key suppliers, potentially leading to favorable terms and a consistent supply of products.

However, the significant reliance on a single supplier—Aurobindo Pharma Limited—could pose risks related to supply chain disruptions, such as production delays or quality control issues. The shipment data reveals a high volume of transactions with Aurobindo Pharma Limited, suggesting a stable and ongoing relationship. Nonetheless, the limited number of suppliers may expose Aurologistics LLC to vulnerabilities if any issues arise with these partners. Diversifying the supplier base could mitigate such risks and enhance the resilience of the company's supply chain.

2Supply Chain Resilience

The resilience of Aurologistics LLC's Indian supply chain is closely tied to the reliability and compliance of its primary suppliers, Aurobindo Pharma Limited and Eugia Pharma Specialities Limited. Both companies are recognized for their adherence to Good Manufacturing Practices (GMP) and have established reputations in the pharmaceutical industry. Aurobindo Pharma Limited, for instance, has a substantial presence in the U.S. market, indicating a robust supply chain capable of meeting demand.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug imports, ensuring that all imported drugs meet standards for quality, safety, and effectiveness. The FDA's import program involves reviewing shipments to determine their admissibility, inspecting products, and taking enforcement actions when necessary to protect public health.

Key legislation governing pharmaceutical imports includes the FD&C Act, which outlines requirements for drug registration, labeling, and manufacturing practices. The FDA's Regulatory Procedures Manual provides detailed guidance on import operations and actions, ensuring that imported drugs comply with U.S. standards. Additionally, the FDA's Investigations Operations Manual outlines procedures for inspecting and evaluating imported drugs, further supporting the regulatory framework for pharmaceutical imports.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. Importers must ensure that their products comply with FDA regulations, including those related to drug registration and listing. While the FDA does not issue import licenses per se, importers must provide Affirmation of Compliance (A of C) codes, such as the Drug Registration Number (REG), Drug Listing Number (DLS), and Drug Application Number (DA), to facilitate FDA review and ensure compliance with regulatory standards.

Frequently Asked Questions — Aurologistics Llc

What products does Aurologistics Llc import from India?

Aurologistics Llc imports 22 pharmaceutical products across 12 categories. Top imports: Rosuvastatin ($4.5M), Metoprolol ($3.3M), Citalopram ($3.0M), Losartan ($3.0M), Clopidogrel ($3.0M).

Who supplies pharmaceuticals to Aurologistics Llc from India?

Aurologistics Llc sources from 2 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (89.7% of imports, $268.0M).

What is Aurologistics Llc's total pharmaceutical import value?

Aurologistics Llc's total pharmaceutical import value from India is $32.8M, based on 715 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Aurologistics Llc focus on?

Aurologistics Llc imports across 12 categories. The largest: Cardiovascular (48.8%), CNS & Psychiatric (14.3%), Antibiotics (8.2%).

Get Full Aurologistics Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Aurologistics Llc

Aurologistics Llc — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Aurologistics Llc?

What Formulations Does Aurologistics Llc Import?

What Products Does Aurologistics Llc Import?

Top Products by Import Value

Aurologistics Llc Therapeutic Categories — 12 Specializations